Showing 1 - 1 results of 1 for search 'Ko Sugibayashi', query time: 0.02s Refine Results
  1. 1
    Safety, tolerability, pharmacokinetics and preliminary antitumour activity of an antisense oligonucleotide targeting STAT3 (danvatirsen) as monotherapy and in combination with durvalumab in Japanese patients with advanced solid malignancies: a phase 1 study

    Safety, tolerability, pharmacokinetics and preliminary antitumour activity of an antisense oligonucleotide targeting STAT3 (danvatirsen) as monotherapy and in combination with durv... by Yasutoshi Kuboki, Tomohiro Nishina, Tomoko Fujita, Naoto Yoshizuka, Ko Sugibayashi, Kosho Murayama

    Published 2022-10-01
    Get full text
    Article

Search Tools: